Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 3060

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 8
Chunk 3060
---
 -  
     (3,680) 
     -  
     - 
  
    Changes in fair value 
     (533) 
     (1,450) 
     (1,573) 
     105  
     - 
  
    Balance as of December 31, 2024 
     (59,056) 
     (5,573) 
     (11,375) 
     (1,089) 
     - 

    Balance 
     (59,056) 
     (5,573) 
     (11,375) 
     (1,089) 
     - 

    F-20

5.
Accounts Payable and Accrued Expenses

Accounts
payable and accrued expenses consisted of the following:

 Schedule
of Accounts Payable and Accrued Expenses

    (in thousands) 
    2024  
    2023 

    For the Years ended 
  
    (in thousands) 
    2024  
    2023 
  
    Accounting and legal fees 
    $10,996  
    $12,099 
  
    Vendor fees 
     3,459  
     2,517 
  
    Research and development 
     645  
     636 
  
    Other 
     799  
     933 
  
    Total accounts payable and accrued expenses 
    $15,899  
    $16,185 

6.
Short-term Loan Agreements

As
of December 31, 2024 and December 31, 2023, the Company had the following short-term loan balances:

 Schedule of Short-term Loan Balances

    Short-term loans: 
    2024  
    2023 

    (in thousands) 
    For the Years ended 
  
    Short-term loans: 
    2024  
    2023 
  
    Second Street Loan 
    $600  
    $600 
  
    Second Street Loan 2 
     400  
     400 
  
    March Second Street Loan 
     700  
     700 
  
    McKra Loan 
     1,000  
     1,000 
  
    Underwriter Promissory Note 
     1,575  
     3,150 
  
    2023 Convertible Note